Suppr超能文献

中国内地 SCA3/MJD 患者的线粒体基因组分析。

Profiling of mitochondrial genomes in SCA3/MJD patients from mainland China.

机构信息

Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, China.

AmCare Genomics Laboratory, Guangzhou, China; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.

出版信息

Gene. 2020 May 15;738:144487. doi: 10.1016/j.gene.2020.144487. Epub 2020 Feb 19.

Abstract

Spinocerebellar ataxia type 3, also known as Machado-Joseph disease (SCA3/MJD), is the most common type of autosomal dominant cerebellar ataxias. Few studies focused on the changes of the whole mitochondrial genomes of SCA3/MJD patients and its relationship with the pathogenesis of SCA3/MJD. We adapted one-step long-range PCR to amplify the entire mitochondrial DNA (mtDNA) followed by next-generation sequencing technology to investigate the information of whole mitochondrial genomes in 38 SCA3/MJD patients and 31 healthy controls from mainland China. Compared to the healthy control group, the mitochondrial variations in SCA3/MJD patients were more concentrated in the tRNA-transcribed genes which were further found to be potentially associated with the pathogenesis of SCA3/MJD by SKAT-O analysis. However, owning variations in tRNA-transcribed genes could not affect the age of onset (AO) of SCA3/MJD patients. We also noticed that the variant loads greater than 90% took up more in SCA3/MJD patients than in controls. Moreover, from our preliminary study, compared to the patients whose ages of onset were elder than 20, the mitochondrial genomes showed no difference in those AO less than 20. This is the first study to demonstrate the feasibility of using the next-generation sequencing technology for mtDNA variant analysis of SCA3/MJD patients from mainland China. And this research enriches the genetic information of SCA3/MJD and provides a direction for further investigations about the mitochondrial genomes in SCA3/MJD.

摘要

脊髓小脑性共济失调 3 型,又称 Machado-Joseph 病(SCA3/MJD),是最常见的常染色体显性小脑共济失调类型。很少有研究关注 SCA3/MJD 患者整个线粒体基因组的变化及其与 SCA3/MJD 发病机制的关系。我们采用一步长距离 PCR 扩增整个线粒体 DNA(mtDNA),然后采用下一代测序技术,对来自中国大陆的 38 名 SCA3/MJD 患者和 31 名健康对照者的整个线粒体基因组信息进行了研究。与健康对照组相比,SCA3/MJD 患者的线粒体变异更集中在 tRNA 转录基因,通过 SKAT-O 分析进一步发现这些变异可能与 SCA3/MJD 的发病机制有关。然而,tRNA 转录基因的变异并不能影响 SCA3/MJD 患者的发病年龄(AO)。我们还注意到,变异负荷大于 90%的变异在 SCA3/MJD 患者中比在对照组中更为常见。此外,从我们的初步研究中可以看出,与发病年龄大于 20 岁的患者相比,发病年龄小于 20 岁的患者的线粒体基因组没有差异。这是第一项研究,证明了使用下一代测序技术对来自中国大陆的 SCA3/MJD 患者 mtDNA 变异进行分析的可行性。这项研究丰富了 SCA3/MJD 的遗传信息,并为进一步研究 SCA3/MJD 中线粒体基因组提供了方向。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验